AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Candidate HIV-1 subtype C DNA vaccine for South Africa characterized.

Vaccine Weekly

| January 21, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 JAN 21 - (NewsRx.com & NewsRx.net) -- Researchers have constructed and characterized a candidate HIV-1 subtype C DNA vaccine for South Africa.

"A candidate DNA vaccine pTHgagC expressing the immunodeficiency virus-1 (HIV-1) gag gene from South African isolate Du422 was constructed and characterized. The isolate was selected on the basis of being the closest to the South African subtype C consensus sequence. Sequence analysis of cytotoxic T lymphocyte (CTL) epitopes showed that HIV subtype C-infected individuals have CTL responses to a number of epitopes present in the vaccine, but also revealed a more limited presence of subtype A- and any B-derived epitopes," investigators in South Africa report.

"A high level of expression of the immunogen was demonstrated in human cells and a potent, long-lived CTL response to a single inoculation of the DNA vaccine was elicited in BALB/c mice, which could be significantly increased by a boost vaccination at four weeks," said Joanne H. van Harmelen and collaborators at the University of Cape Town in South Africa and the Weatherall Institute of Molecular Medicine in ...

Related articles from newspapers, magazines, journals, and more
Candidate HIV-1 subtype C DNA vaccine for South Africa characterized.
Newspaper article from: AIDS Weekly January 19, 2004 700+ words
...characterized a candidate HIV-1 subtype C DNA vaccine for South Africa. "A candidate DNA vaccine pTHgagC expressing the immunodeficiency...characterisation of a candidate HIV-1 subtype C DNA vaccine for South Africa. Vaccine, 2003;21(27-30...
Powderject DNA vaccine achieves protective immunity.(Brief Article)
Newspaper article from: BIOTECH Patent News April 1, 2001 700+ words
...achievement of protective immunity by a DNA vaccine in volunteers who do not respond to...preliminary data from the hepatitis B DNA vaccine clinical study will be presented at...study is part of PowderJect's major DNA vaccine collaboration with GlaxoSmithKline...
PowderJect DNA Vaccine First to Achieve Protective Immunity in Non-Responders...
Press release article from: PR Newswire April 24, 2001 700+ words
...achievement of protective immunity by a DNA vaccine in volunteers who do not respond to...preliminary data from the hepatitis B DNA vaccine clinical study will be presented today...study is part of PowderJect's major DNA vaccine collaboration with GlaxoSmithKline...
Vical Introduces RapidResponse(TM) DNA Vaccine Cell-Free Platform Designed to...
Press release article from: PR Newswire June 4, 2007 700+ words
...today announced the RapidResponse(TM) DNA vaccine platform designed to produce large quantities...of Vical. "The RapidResponse(TM) DNA vaccine platform has the potential to develop...genetic sequence." RapidResponse(TM) DNA vaccine manufacturing involves a cell-free...
DNA vaccine protected chimps from AIDS virus, scientists say.(Originated from...
Newspaper article from: Knight Ridder/Tribune News Service Collins, Huntly Shaw, Donna April 29, 1997 700+ words
...infection with the AIDS virus. The DNA vaccine is made with the genetic material of...are the first to demonstrate that a DNA vaccine can confer protection against HIV in...achieve protection in chimps with a DNA vaccine,'' said William Paul, an immunologist...
Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant...
Press release article from: PR Newswire June 25, 2008 700+ words
...advancing with the development of a DNA vaccine manufacturing process with the potential...Platform The RapidResponse(TM) DNA vaccine manufacturing platform is intended to...dedicated facilities. RapidResponse(TM) DNA vaccine manufacturing involves a cell-free...
Vical's DNA Vaccine Provides Complete Protection Against Avian Influenza and...
Press release article from: PR Newswire May 2, 2006 700+ words
...three-component influenza (flu) DNA vaccine candidate provided 100 protection in...the company's program to develop a DNA vaccine that protects humans against emerging...toward human testing of the pandemic flu DNA vaccine candidate. "We are encouraged by the...
Vical Receives $6 Million Grant From NIH to Advance RapidResponse(TM) DNA...
Press release article from: PR Newswire June 12, 2007 700+ words
...NIH), for further development of a DNA vaccine manufacturing process with the potential...Platform The RapidResponse(TM) DNA vaccine manufacturing platform is intended to...dedicated facilities. RapidResponse(TM) DNA vaccine manufacturing involves a cell-free...
DNA vaccine against Streptococcus mutans characterized.
Newspaper article from: Health & Medicine Week May 3, 2004 700+ words
...characterized a fusion anti-caries DNA vaccine against PAc and glucosyltransferase...against caries, we constructed a fusion DNA vaccine, pGLUA-P, by cloning the GLU region of GTF into a DNA vaccine, pCIA-P, which encodes two highly...
CytoDyn DNA Vaccine Shows Promise for Low-Dose Protection from Bird Flu,...
Press release article from: Business Wire August 8, 2007 700+ words
...The gene gun is used to deliver a DNA vaccine for bird flu directly into human cells...ubiquitous hypodermic. PowderMed's DNA vaccine is reported to be an older version of...development of CytoDyn's more effective DNA vaccine could provide PowderMed with a means...
For more facts and information, see all results

Source: HighBeam Research, Candidate HIV-1 subtype C DNA vaccine for South Africa characterized.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA